|
|
M-039 / M-039-1ML updated item number format
Meprobamate
1.0 mg/mL in Methanol | Certified Reference Material
|
Meprobamate is marketed as an anti-anxiety drug and muscle relaxant under the trade names Milltown, Meprospan, and Equanil. This Certified Spiking Solution® is suitable for GC/MS or LC/MS testing applications in forensic analysis, clinical toxicology, urine drug testing, or pain prescription monitoring.
|
|
|
|
Concentration:
|
1.0 mg/mL
|
Solvent:
|
Methanol
|
Unit Size:
|
1 mL/ampoule
|
CAS Number:
|
57-53-4
|
Chemical Formula:
|
C9H18N2O4
|
Molecular Weight:
|
218.25
|
Certificate of Analysis:
|
|
US List Price:
|
|
|
|
| C-077 / C-077-1ML |
|
Carisoprodol, 1.0 mg/mL
|
|
$38.90
|
|
|
|
|
| C-083 / C-083-1ML |
|
Carisoprodol-D7, 100 μg/mL
|
|
$191.00
|
|
|
|
|
| C-123 / C-123-1ML |
|
Carisoprodol-D7, 1.0 mg/mL
|
|
$1,830.00
|
|
|
|
|
| C-134 / C-134-1ML |
|
Carisoprodol-13C3, 100 µg/mL
|
|
$214.00
|
|
|
|
|
| M-073 / M-073-1ML |
|
Meprobamate-D7 (2-methyl-1,3-propanediol-D7), 1.0 mg/mL
|
|
$407.00
|
|
|
|
|
| M-131 / M-131-1ML |
|
Meprobamate-D7 (propyl-D7), 100 μg/mL
|
|
$168.00
|
|
|
|
|
| M-178 / M-178-1ML |
|
Meprobamate-13C3, 100 μg/mL
|
|
$235.00
|
|
|
|
|
| M-181 / M-181-1ML |
|
Meprobamate-D3, 100 µg/mL
|
|
$161.00
|
|
|
|
|
Regulatory Control ▶ USDEA exempt chemical preparation - no USDEA registration or paperwork required ▶ Canada Test Kit Registration # 61-1302 - no Health Canada import authorization required
read more about ordering regulated substances
UN Number, Class, PG 1230, 3, II
Safety Data Sheet
HS Code
3822.90.0000
▶ High Throughput Screening and confirmation of 41 Pain Panel Drugs in Oral Fluid by an Integrated On-Line Extraction UHPLC-MS/MS System | Louis Maljers, Zicheng Yang, Bruker Daltonics Inc, 2016
|
▶ Proof of Concept for Automated SPE/HPLC/MS/MS Methods to Replace Traditional Immunoassay with MS Confirmation of Driving Under the Influence Samples | Robert M. Sears, Toxicology Technical Leader , Kenneth Lewis, CEO , and Kim Gamble, President, ITSP Solutions, INC., 2014
|
|
|
|
|